Evidence map›Paper›PMID 32333199›Full record

ArticlePathology oncology research : POR2020

Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19.

Evangelos Tsiambas, Vasileios Papanikolaou, Aristeidis Chrysovergis, Nicholas Mastronikolis, Vasileios Ragos, Nikolaos Kavantzas, Andreas C Lazaris, Efthymios Kyrodimos

Open access · bronzeAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathology oncology research : POR, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Evangelos TsiambasDepartment of Cytology, 401 & 417 VA Hospital (NIMTS), Athens, Greece. tsiambasecyto@yahoo.gr.
Vasileios Papanikolaou1st ENT Department, Hippocration Hospital, University of Athens, Athens, Greece.
Aristeidis Chrysovergis1st ENT Department, Hippocration Hospital, University of Athens, Athens, Greece.
Nicholas MastronikolisDepartment of Otorhinolaryngology, Head and Neck Surgery, Medical School, University of Patras, Patras, Greece.
Vasileios RagosDepartment of Maxillofacial Surgery, School of Health Sciences, University of Ioannina, Ioannina, Greece.
Nikolaos KavantzasDepartment of Pathology, Medical School, National and Kapodistrian University of Athens, 17 Patriarchou Grigoriou E΄ Street, Ag. Paraskevi, 153 41, Athens, Greece.
Andreas C LazarisDepartment of Pathology, Medical School, National and Kapodistrian University of Athens, 17 Patriarchou Grigoriou E΄ Street, Ag. Paraskevi, 153 41, Athens, Greece.
Efthymios Kyrodimos1st ENT Department, Hippocration Hospital, University of Athens, Athens, Greece.
National and Kapodistrian University of Athens · GRHippocration General Hospital · GRNIMTS Hospital · GRUniversity of Ioannina · GRUniversity of Patras · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BetacoronavirusCoronavirus InfectionsHematologic NeoplasmsPandemicsPneumonia, ViralAngiotensin-Converting Enzyme 2BiomarkersCOVID-19HumansImmunocompromised HostPeptidyl-Dipeptidase APolymorphism, Single NucleotideSARS-CoV-2ACE2 protein, humanAngiotensin-Converting Enzyme 2BiomarkersPeptidyl-Dipeptidase A

Identifiers

PMID32333199
PMCPMC7182393
OpenAlexW3017583471

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.